Daylife Select
A point & click tool to create dynamic content portals. Learn More »
After successfully closing a merger with Wyeth last month, pharmaceutical colossus Pfizer (PFE) announced plans to close six of its research locations in an effort to consolidate the newly-expanded company’s research operations. Full Article at FOX Business
Related Articles
-
10 November 2009 Just shy of a month since the closing of the $68 billion acquisition of Wyeth, Pfizer has announced a major restructuring of its research operations which will see the closure of six facilities. Full Article at PharmaTimes
-
Pfizer Inc. , which bought rival Wyeth last month, said yesterday that it would move "a number of functions" from Wyeth's Collegeville, Montgomery County, location as Pfizer consolidated research and development at five "hub" sites. Full Article at Philadelphia Inquirer
-
Nov. 9 (Bloomberg) -- Pfizer Inc. , the world’s biggest drugmaker, plans to shutter six research centers, following its acquisition of Wyeth. Full Article at Bloomberg.com
-
RESEARCH TRIANGLE PARK, N.C. — Pfizer (NYSE: PFE), the world's biggest drugmaker, is closing two research and development operations in North Carolina and four others among 20 in the company, reorganizing and consolidating others, and cutting the jobs... Full Article at WRAL
